Share chart United Therapeutics Corporation
Extended chart
Simple chart
About
United Therapeutics Corporation, биотехнологическая компания, занимается разработкой и коммерциализацией продуктов для удовлетворения неудовлетворенных медицинских потребностей пациентов с хроническими и опасными для жизни заболеваниями в Соединенных Штатах и за рубежом.
More detailsP/E | 12.96 |
---|---|
P/S | 2.61 |
P/BV | 1.36 |
EV/EBITDA | -32.27 |
EBITDA | -0.1208 |
Цена ао | 358.35 |
Число акций ао | 0.0497 млрд |
Сайт | http://www.unither.com |
Выручка | 1.45 |
Див.доход ао | 0 |
ISIN | US91307C1027 |
Валюта | usd |
IPO date | 1999-06-17 |
Sector | Health Care |
Industry | Biotechnology |
Валюта отчета | usd |
Change price per day: | -0% (358.22) |
---|---|
Change price per week: | +2.39% (349.85) |
Change price per month: | +5.78% (338.65) |
Change price per 3 month: | +9.15% (328.19) |
Change price per half year: | +52.23% (235.31) |
Change price per year: | +53.81% (232.9) |
Change price per 3 year: | +92.22% (186.36) |
Change price per 5 year: | +352.36% (79.19) |
Change price per year to date: | +57.96% (226.78) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
30.09.2024 | 30.09.2024 | JAMES EDGEMOND Officer |
Purchase | 358.62 | 2 794 370 | 7792 | 0 | 0.02 | link |
23.09.2024 | 23.09.2024 | JAMES EDGEMOND Officer |
Purchase | 354.04 | 2 760 100 | 7796 | 0 | 0.02 | link |
16.09.2024 | 16.09.2024 | JAMES EDGEMOND Officer |
Purchase | 339.12 | 2 648 530 | 7810 | 0 | 0.02 | link |
03.09.2024 | 03.09.2024 | JAMES EDGEMOND Officer |
Purchase | 362.37 | 2 821 050 | 7785 | 0 | 0.02 | link |
26.08.2024 | 26.08.2024 | JAMES EDGEMOND Officer |
Purchase | 347.6 | 2 710 930 | 7799 | 0 | 0.02 | link |
14.08.2024 | 15.08.2024 | ROTHBLATT MARTINE A Chairperson & CEO |
Sale | 324.5 | 1 168 200 | 3600 | 0 | -0.01 | link |
14.08.2024 | 15.08.2024 | ROTHBLATT MARTINE A Chairperson & CEO |
Purchase | 129.49 | 466 164 | 3600 | 0 | 0.01 | link |
13.08.2024 | 15.08.2024 | ROTHBLATT MARTINE A Chairperson & CEO |
Sale | 327.84 | 1 180 220 | 3600 | 0 | -0.01 | link |
07.08.2024 | 07.08.2024 | DANIEL CARLSON TTEE BENKOWITZ Officer |
Purchase | 323.4 | 1 617 000 | 5000 | 0 | 0.01 | link |
31.07.2024 | 02.08.2024 | ROTHBLATT MARTINE A Chairperson & CEO |
Sale | 318.39 | 1 146 200 | 3600 | 0 | -0.01 | link |
31.07.2024 | 02.08.2024 | ROTHBLATT MARTINE A Chairperson & CEO |
Purchase | 129.49 | 466 164 | 3600 | 0 | 0.01 | link |
22.07.2024 | 23.07.2024 | ROTHBLATT MARTINE A Chairperson & CEO |
Sale | 331.32 | 1 192 750 | 3600 | 0 | -0.01 | link |
22.07.2024 | 23.07.2024 | ROTHBLATT MARTINE A Chairperson & CEO |
Purchase | 129.49 | 466 164 | 3600 | 0 | 0.01 | link |
19.07.2024 | 23.07.2024 | ROTHBLATT MARTINE A Chairperson & CEO |
Sale | 329.59 | 1 186 520 | 3600 | 0 | -0.01 | link |
19.07.2024 | 23.07.2024 | ROTHBLATT MARTINE A Chairperson & CEO |
Purchase | 129.49 | 466 164 | 3600 | 0 | 0.01 | link |
26.06.2024 | 28.06.2024 | Thompson Tommy G Director |
Sale | 319.34 | 2 395 050 | 7500 | 0 | -0.02 | link |
26.04.2024 | 29.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 235.2 | 846 720 | 3600 | 0 | -0.01 | link |
26.04.2024 | 29.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 129.49 | 466 164 | 3600 | 0 | 0.01 | link |
25.04.2024 | 29.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 235.53 | 847 908 | 3600 | 0 | -0.01 | link |
25.04.2024 | 29.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 129.49 | 466 164 | 3600 | 0 | 0.01 | link |
24.04.2024 | 25.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 238.81 | 859 716 | 3600 | 0 | -0.01 | link |
24.04.2024 | 25.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 129.49 | 466 164 | 3600 | 0 | 0.01 | link |
23.04.2024 | 25.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 236.38 | 850 968 | 3600 | 0 | -0.01 | link |
23.04.2024 | 25.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 129.49 | 466 164 | 3600 | 0 | 0.01 | link |
12.04.2024 | 15.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 235.42 | 847 512 | 3600 | 0 | -0.01 | link |
12.04.2024 | 15.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 129.49 | 466 164 | 3600 | 0 | 0.01 | link |
11.04.2024 | 15.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 238.96 | 860 256 | 3600 | 0 | -0.01 | link |
11.04.2024 | 15.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 129.49 | 466 164 | 3600 | 0 | 0.01 | link |
10.04.2024 | 11.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 237.27 | 3 274 330 | 13800 | 0 | -0.03 | link |
10.04.2024 | 11.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 129.49 | 1 786 960 | 13800 | 0 | 0.03 | link |
09.04.2024 | 11.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 237.16 | 3 557 400 | 15000 | 0 | -0.03 | link |
09.04.2024 | 11.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 129.49 | 1 942 350 | 15000 | 0 | 0.03 | link |
08.04.2024 | 09.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 129.49 | 655 219 | 5060 | 0 | 0.01 | link |
08.04.2024 | 09.04.2024 | DWEK RAYMOND Director |
Purchase | 88.03 | 352 120 | 4000 | 0 | 0.01 | link |
08.04.2024 | 09.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 237.52 | 1 201 850 | 5060 | 0 | -0.01 | link |
05.04.2024 | 09.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 129.49 | 1 942 350 | 15000 | 0 | 0.03 | link |
05.04.2024 | 09.04.2024 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 235.06 | 3 525 900 | 15000 | 0 | -0.03 | link |
21.09.2023 | 22.09.2023 | MAHON PAUL A EVP & GENERAL COUNSEL |
Sale | 222.19 | 1 333 140 | 6000 | 0 | -0.01 | link |
21.09.2023 | 22.09.2023 | MAHON PAUL A EVP & GENERAL COUNSEL |
Purchase | 117.76 | 706 560 | 6000 | 0 | 0.01 | link |
23.11.2022 | 25.11.2022 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 268.56 | 2 148 480 | 8000 | 0 | -0.02 | link |
23.11.2022 | 25.11.2022 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Purchase | 113.08 | 904 640 | 8000 | 0 | 0.02 | link |
22.11.2022 | 25.11.2022 | ROTHBLATT MARTINE A CHAIRPERSON & CEO |
Sale | 268.29 | 2 146 320 | 8000 | 0 | -0.02 | link |
26.05.2022 | 26.05.2022 | Thompson Tommy G Director |
Purchase | 48.11 | 105 842 | 2200 | 0 | 0 | link |
26.05.2022 | 26.05.2022 | DWEK RAYMOND Director |
Purchase | 63.9 | 319 500 | 5000 | 0 | 0.01 | link |
Institutions | Volume | Share, % |
---|---|---|
Blackrock Inc. | 5295000 | 11.25 |
Vanguard Group Inc | 4673678 | 9.93 |
Wellington Management Group, LLP | 3794010 | 8.06 |
Avoro Capital Advisors LLC | 2858888 | 6.08 |
FMR, LLC | 2321040 | 4.93 |
Renaissance Technologies, LLC | 2170214 | 4.61 |
State Street Corporation | 1947177 | 4.14 |
Janus Henderson Group PLC | 870119 | 1.85 |
Geode Capital Management, LLC | 779762 | 1.66 |
Dimensional Fund Advisors LP | 561950 | 1.19 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Michael I. Benkowitz | President & COO | 2.83M | 1972 (52 years) |
Mr. James C. Edgemond | CFO & Treasurer | 2.01M | 1968 (56 years) |
Ms. Holly Hobson | Associate Vice President of Human Resources | N/A | |
Kevin T. Gray | Senior Vice President of Strategic Operations & Logistics | N/A | |
Mr. Patrick Poisson | Executive VP of Technical Operations | N/A | 1968 (56 years) |
Mr. Gil Golden | Senior VP & Chief Medical Officer | N/A | |
Mr. Dewey Steadman C.F.A. | Head of Investor Relations | N/A | |
Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D. | Founder, Chairman & CEO | 5.32M | 1955 (69 years) |
Mr. Paul A. Mahon J.D. | Executive VP, General Counsel & Corporate Secretary | 2.31M | 1964 (60 years) |
Dr. Leigh Peterson | Executive Vice President of Product Development & Xenotransplantation | N/A |
Address: United States, Silver Spring, MD , 1040 Spring Street - open in Google maps, open in Yandex maps
Website: http://www.unither.com
Website: http://www.unither.com